Litcius/Paper detail

Benefit-Risk Profile of P2X3 Receptor Antagonists for Treatment of Chronic Cough

Shota Yamamoto, Nobuyuki Horita, Johsuke Hara, M Sasamoto, Yoshihiro Kanemitsu, Yu Hara, Yasushi Obase, Takeshi Kaneko, Akio Niimi, Hiroshi Mukae

2024CHEST Journal19 citationsDOI

Topics & Concepts

MedicineDiscontinuationConfidence intervalAdverse effectInternal medicineRegimenRandomized controlled trialAnesthesiaRespiratory and Cough-Related ResearchDysphagia Assessment and ManagementChronic Obstructive Pulmonary Disease (COPD) Research
Benefit-Risk Profile of P2X3 Receptor Antagonists for Treatment of Chronic Cough | Litcius